← FDA DRUG APPROVALS
FDA ANDA · ANDA219404
OXCARBAZEPINE EXTENDED RELEASE TABLETS
Sponsor: LUPIN LIMITED
APPLICATION
ANDA219404
TYPE
ANDA
ROUTE
EXTENDED RELEASE
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
OXCARBAZEPINE EXTENDED RELEASE TABLETSNone (Tentative Approval)
OXCARBAZEPINE 300MG · TABLET · EXTENDED RELEASE
OXCARBAZEPINE EXTENDED RELEASE TABLETSNone (Tentative Approval)
OXCARBAZEPINE 600MG · TABLET · EXTENDED RELEASE
Approval history
2025-06-06UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.